
TY  - JOUR
TI  - Posters
JO  - Transplant International
JA  - Transpl Int
VL  - 31
IS  - S5
SN  - 0934-0874
UR  - https://doi.org/10.1111/tri.13350
DO  - doi:10.1111/tri.13350
SP  - 28
EP  - 43
PY  - 2018
ER  - 

TY  - JOUR
TI  - Scientific Section
JO  - Transfusion
VL  - 52
IS  - s3
SN  - 0041-1132
UR  - https://doi.org/10.1111/j.1537-2995.2012.03833_1.x
DO  - doi:10.1111/j.1537-2995.2012.03833_1.x
SP  - 10A
EP  - 229A
PY  - 2012
ER  - 

TY  - JOUR
TI  - Posters
JO  - Fundamental & Clinical Pharmacology
VL  - 18
IS  - s1
SN  - 0767-3981
UR  - https://doi.org/10.1111/j.1472-8206.2004.00260.x
DO  - doi:10.1111/j.1472-8206.2004.00260.x
SP  - 23
EP  - 126
PY  - 2004
ER  - 

TY  - JOUR
TI  - Forensic Psychology and Law
JO  - International Journal of Psychology
JA  - Int J Psychol
VL  - 51
IS  - S1
SN  - 0020-7594
UR  - https://doi.org/10.1002/ijop.12319
DO  - doi:10.1002/ijop.12319
SP  - 597
EP  - 608
PY  - 2016
ER  - 

TY  - JOUR
TI  - Oral Sessions
JO  - Pediatric Diabetes
VL  - 13
IS  - s17
SN  - 1399-543X
UR  - https://doi.org/10.1111/j.1399-5448.2012.00918.x
DO  - doi:10.1111/j.1399-5448.2012.00918.x
SP  - 15
EP  - 45
PY  - 2012
ER  - 

TY  - JOUR
TI  - Abstracts cont.
JO  - Clinical Microbiology and Infection
VL  - 11
IS  - s2
SN  - 1198-743X
UR  - https://doi.org/10.1111/j.1469-0691.2005.clm_1134_04.x
DO  - doi:10.1111/j.1469-0691.2005.clm_1134_04.x
SP  - 546
EP  - 646
PY  - 2005
ER  - 

TY  - JOUR
TI  - Thematic Poster Sessions – Sunday
JO  - Allergy
VL  - 66
IS  - s94
SN  - 0105-4538
UR  - https://doi.org/10.1111/j.1398-9995.2011.02606.x
DO  - doi:10.1111/j.1398-9995.2011.02606.x
SP  - 164
EP  - 319
PY  - 2011
ER  - 

TY  - JOUR
TI  - INVITED SPEAKERS FOR SCIENTIFIC SESSIONS
JO  - Cephalalgia
VL  - 25
IS  - 10
SN  - 0333-1024
UR  - https://doi.org/10.1111/j.1468-2982.2005.01040_3.x
DO  - doi:10.1111/j.1468-2982.2005.01040_3.x
SP  - 842
EP  - 845
PY  - 2005
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - HPB
VL  - 9
IS  - S2
SN  - 1365-182X
UR  - https://doi.org/10.1080/13651820701427987
DO  - doi:10.1080/13651820701427987
SP  - 3
EP  - 76
PY  - 2007
ER  - 

TY  - JOUR
TI  - Poster Session: Haemostasis and Thrombosis
JO  - British Journal of Haematology
VL  - 149
IS  - s1
SN  - 0007-1048
UR  - https://doi.org/10.1111/j.1365-2141.2010.08116_1.x
DO  - doi:10.1111/j.1365-2141.2010.08116_1.x
SP  - 27
EP  - 96
PY  - 2010
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Sleep and Biological Rhythms
JA  - Sleep and Biological Rhythms
VL  - 12
IS  - S1
SN  - 1446-9235
UR  - https://doi.org/10.1111/sbr.12082
DO  - doi:10.1111/sbr.12082
SP  - 1
EP  - 85
PY  - 2014
ER  - 

TY  - JOUR
AU  - Takahashi, Kazuhiro
AU  - Jafri, Syed-Mohammed R.
AU  - Safwan, Mohamed
AU  - Abouljoud, Marwan S.
AU  - Nagai, Shunji
C7  - e13613
TI  - Peri-transplant lactate levels and delayed lactate clearance as predictive factors for poor outcomes after liver transplantation: A propensity score–matched study
JO  - Clinical Transplantation
JA  - Clin Transplant
VL  - 33
IS  - 7
SN  - 0902-0063
UR  - https://doi.org/10.1111/ctr.13613
DO  - doi:10.1111/ctr.13613
SP  - e13613
KW  - complication
KW  - early allograft dysfunction
KW  - ischemia time
KW  - prognosis
KW  - survival
PY  - 2019
AB  - Abstract This study aimed to investigate risk factors for early allograft dysfunction (EAD) and outcomes after liver transplantation (LT), focusing on peri-transplant lactate clearance. We reviewed patients who underwent deceased donor LTs between 2011 and 2014. Lactate levels were checked at reperfusion and at the time of intensive care unit admission. Early lactate clearance was defined as reduction rate of lactate between the times of reperfusion and immediately after LT. Patients were categorized into the normal and delayed clearance groups. We used propensity score matching (PSM) between these two groups to estimate an impact of lactate clearance on incidence of EAD and graft survival. A total of 256 recipients were eligible for this study. Cut-off value of lactate clearance to predict occurrence of EAD was determined at 0.2 mmol/L/h. After PSM, 120 patients in the normal clearance and 36 patients in the delayed clearance group were matched. Delayed lactate clearance was considered as an independent risk factor for EAD (Odds ratio 3.49, P = 0.002). The adjusted hazard of one-year graft loss was significantly increased in the delayed clearance group (hazard ratio 6.69, P = 0.001). In conclusion, peri-transplant delayed lactate clearance may be a strong predictor for EAD and poor liver graft outcomes.
ER  - 

TY  - JOUR
TI  - ACVIM ABSTRACTS
JO  - Journal of Veterinary Internal Medicine
VL  - 13
IS  - 3
SN  - 0891-6640
UR  - https://doi.org/10.1111/j.1939-1676.1999.tb02182.x
DO  - doi:10.1111/j.1939-1676.1999.tb02182.x
SP  - 217
EP  - 287
PY  - 1999
ER  - 

TY  - JOUR
TI  - Elevator Pitch Presentation
JO  - Transplant International
JA  - Transpl Int
VL  - 32
IS  - S2
SN  - 0934-0874
UR  - https://doi.org/10.1111/tri.13510
DO  - doi:10.1111/tri.13510
SP  - 264
EP  - 278
PY  - 2019
ER  - 

TY  - JOUR
TI  - Poster Sessions
JO  - Pediatric Diabetes
JA  - Pediatric Diabetes
VL  - 16
IS  - S21
SN  - 1399-543X
UR  - https://doi.org/10.1111/pedi.12309
DO  - doi:10.1111/pedi.12309
SP  - 50
EP  - 150
PY  - 2015
ER  - 

TY  - JOUR
TI  - Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction 2014 Winter Meeting February 25–March 1, 2014 Doral Golf Resort & Spa Miami, Florida
JO  - Neurourology and Urodynamics
JA  - Neurourol. Urodynam.
VL  - 33
IS  - 2
SN  - 0733-2467
UR  - https://doi.org/10.1002/nau.22577
DO  - doi:10.1002/nau.22577
SP  - 162
EP  - 266
PY  - 2014
ER  - 

TY  - JOUR
TI  - Poster Session 2: Hepatitis C: Therapeutics (Approved Agents)
JO  - Hepatology
JA  - Hepatology
VL  - 62
IS  - S1
SN  - 0270-9139
UR  - https://doi.org/10.1002/hep.28228
DO  - doi:10.1002/hep.28228
SP  - 714A
EP  - 807A
PY  - 2015
ER  - 

TY  - JOUR
TI  - UNMODERATED POSTER PRESENTATIONS
JO  - The Journal of Sexual Medicine
VL  - 7
IS  - s4
SN  - 1743-6095
UR  - https://doi.org/10.1111/j.1743-6109.2010.01995_3.x
DO  - doi:10.1111/j.1743-6109.2010.01995_3.x
SP  - 211
EP  - 239
PY  - 2010
ER  - 

TY  - JOUR
TI  - MODERATED (ORAL) POSTER PRESENTATIONS
JO  - The Journal of Sexual Medicine
VL  - 7
IS  - s4
SN  - 1743-6095
UR  - https://doi.org/10.1111/j.1743-6109.2010.01995_2.x
DO  - doi:10.1111/j.1743-6109.2010.01995_2.x
SP  - 183
EP  - 211
PY  - 2010
ER  - 

TY  - JOUR
AU  - Ichii, Hirohito
AU  - Pileggi, Antonello
AU  - Molano, R. Damaris
AU  - Baidal, David A.
AU  - Khan, Aisha
AU  - Kuroda, Yoshikazu
AU  - Inverardi, Luca
AU  - Goss, John A.
AU  - Alejandro, Rodolfo
AU  - Ricordi, Camillo
TI  - Rescue Purification Maximizes the Use of Human Islet Preparations for Transplantation
JO  - American Journal of Transplantation
VL  - 5
IS  - 1
SN  - 1600-6135
UR  - https://doi.org/10.1111/j.1600-6143.2005.00698.x
DO  - doi:10.1111/j.1600-6143.2005.00698.x
SP  - 21
EP  - 30
KW  - Islet transplantation
KW  - density gradient purification
KW  - islets of Langerhans
KW  - potency test
KW  - graft function
KW  - rescue purification
PY  - 2005
AB  - The relative inefficiency of the islet purification process may hamper obtaining enough islets for transplantation even with adequate pre-purification counts. In this study, we determined the effect of an additional purification step on total islet yields and pancreas utilization at our center. Twenty-five pancreata were processed using the automated method followed by continuous gradient purification (CGP), and the less pure islet fractions were subjected to additional rescue gradient purification (RGP). CGP and RGP islets were combined and transplanted into patients with type 1 diabetes. CGP and RGP islets showed no significant differences in cell viability, insulin secretion in vitro and function when transplanted into chemically diabetic mice. Mean RGP contribution to the final preparation was 27.9 ± 19.9%. In 12 of 25 preparations, CGP yielded <5000 IEQ/kg of recipient body weight, and inclusion of RGP islets to the final preparation allowed to obtain the minimal islet number required for transplantation. Transplanted islets resulted in sustained C-peptide production, HbA1C normalization and insulin-independence or reduced insulin requirements. Taken together, our data suggest that RGP islets are comparable in terms of viability and potency to CGP islets. RGP may be of assistance in maximizing the number of islet preparations successfully used in transplant protocols.
ER  - 
